MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 113 filers reported holding MERUS N V in Q2 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $628,761 | -15.1% | 26,665 | -5.2% | 0.00% | 0.0% |
| Q2 2023 | $740,347 | +5374.3% | 28,118 | +3725.6% | 0.00% | – |
| Q1 2023 | $13,524 | -14.7% | 735 | -28.3% | 0.00% | – |
| Q4 2022 | $15,857 | -99.9% | 1,025 | -23.0% | 0.00% | – |
| Q3 2022 | $26,660,000 | -35.0% | 1,331 | -26.5% | 0.00% | – |
| Q2 2022 | $41,001,000 | +77.6% | 1,811 | +107.4% | 0.00% | – |
| Q1 2022 | $23,082,000 | +3721.5% | 873 | +4494.7% | 0.00% | – |
| Q4 2021 | $604,000 | -92.5% | 19 | -94.8% | 0.00% | – |
| Q3 2021 | $8,074,000 | +3.3% | 367 | -1.1% | 0.00% | – |
| Q2 2021 | $7,817,000 | +107.9% | 371 | +106.1% | 0.00% | – |
| Q1 2021 | $3,760,000 | – | 180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $32,048,000 | 13.34% |
| Lynx1 Capital Management LP | 613,071 | $12,280,000 | 11.08% |
| Aquilo Capital Management, LLC | 1,507,109 | $30,187,000 | 10.88% |
| COMMODORE CAPITAL LP | 2,615,762 | $52,394,000 | 8.42% |
| MPM BioImpact LLC | 918,310 | $18,394,000 | 4.36% |
| BVF INC/IL | 3,444,420 | $68,992,000 | 2.85% |
| Boxer Capital, LLC | 1,900,000 | $38,057,000 | 2.14% |
| Opaleye Management Inc. | 253,200 | $5,072,000 | 2.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 295,136 | $5,912,000 | 2.00% |
| TCG Crossover Management, LLC | 300,000 | $6,009,000 | 1.80% |